| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:58945766:1838 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:58945766:1838?format=raw |
LEADER: 01838fam a2200313 a 4500
001 4052158
005 20221027024827.0
008 951010s1996 enka b 001 0 eng
010 $a 95045603
020 $a0750617640
035 $a(OCoLC)33358004
035 $a(OCoLC)ocm33358004
035 $9ALR3282HS
035 $a(NNC)4052158
035 $a4052158
040 $aDLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRM312$b.F443 1996
082 00 $a615/.773$220
100 1 $aFeldman, Stanley A.$0http://id.loc.gov/authorities/names/n79089599
245 10 $aNeuromuscular block /$cStanley Feldman.
260 $aOxford ;$aBoston :$bButterworth-Heinemann,$c1996.
300 $ax, 180 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tHistory --$g2.$tThe neuromuscular junction --$g3.$tNeuromuscular transmission --$g4.$tAcetylcholine formation and metabolism --$g5.$tNeuromuscular block - non-depolarizing block --$g6.$tIsolated arm experiments --$g7.$tExplanations of clinical events based on biophase binding --$g8.$tPharmacokinetics and pharmacokinetic models --$g9.$tOnset of action of non-depolarizing drugs --$g10.$tPresynaptic nicotinic receptors --$g11.$tReversing the action of non-depolarizing drugs --$g12.$tSensitivity to a second drug dose --$g13.$tThe priming principle --$g14.$tDepolarizing neuromuscular block --$g15.$tHypothermia and neuromuscular block --$g16.$tMonitoring neuromuscular conduction --$g17.$tThe ideal muscle relaxant --$g18.$tThe muscle relaxant drugs.
650 0 $aNeuromuscular blocking agents.$0http://id.loc.gov/authorities/subjects/sh85091144
650 2 $aNeuromuscular Blocking Agents.$0https://id.nlm.nih.gov/mesh/D009466
852 00 $boff,hsl$hRM312$i.F443 1996